Clinical trials
Metabolic Syndrome trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 15 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Korea University | 6 |
| Korea University Anam Hospital | 4 |
| Yonsei University | 4 |
| Pusan National University Hospital | 3 |
| Seoul National Hospital | 3 |
| Seoul National University Hospital | 3 |
| Gachon University Gil Oriental Medical Hospital | 2 |
| Hanyang University | 2 |
| JW Pharmaceutical | 2 |
| Ministry of Food and Drug Safety, Korea | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 53 |
| Obesity | 9 |
| Schizophrenia | 5 |
| Atherosclerosis | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Dyslipidemias | 3 |
| Inflammation | 3 |
| Hypertension | 2 |
| Metabolic Diseases | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
Trials
Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.